In vitro cytotoxicity studies with the MMAE-Pep11 conjugate demonstrated that this peptide-drug conjugate can selectively kill EGFR overexpressing cancer cells while having lower toxicity towards non EGFR expressing normal cells. This evidence concerns the gene EGFR and cancer.